News
-
PackGene Supports NeueXcell Therapeutics’ NXL-001 Alzheimer’s Gene Therapy Clinical Milestone
Jun 12 2025 -
Starrygene’s AAV Bispecific Antibody Gene Therapy for wAMD Advances to Phase II with Support from PackGene
May 25 2025 -
PackGene Supports Patient Family-Driven World’s First GM2 AB Variant Gene Therapy Clinical Trial
May 24 2025 -
PackGene to Showcase Scalable AAV Manufacturing, AI-Driven Capsid Engineering, and End-to-End CDMO Solutions at ASGCT 2025
May 12 2025 -
Guangzhou First People’s Hospital Successfully Administers Southern China’s First Gaucher Disease Gene Therapy
Mar 03 2025 -
A Global Alliance to Save Lives: How Two Parents and PackGene Are Redefining What’s Possible in Gene Therapy with Help from Weill Cornell Medicine
Jan 08 2025 -
Warm Congratulations to Reforgene Medicine on Clinical Trial Approval in China for RM-101, the World’s First Self-Developed Ophthalmic Gene-Editing Therapy
Oct 11 2024 -
Warm congratulations to GeneVector on the IND approval of its AAV gene therapy drug, the first to adopt a two-plasmid packaging system
Feb 22 2024 -
Lingyi Biotech’s LY-M001, China’s First Gene Therapy Drug for Type 1 Gaucher Disease, Receives NMPA Implied Approval for IND
Jan 16 2024